SEC Form 5
FORM 5

[  ] Check this box if no longer
subject to Section 16. Form 4 or Form 5 obligations may continue.
See Instruction 1(b).

[  ] Form 3 Holdings Reported

[  ] Form 4 Transactions Reported
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
OMB APPROVAL



OMB Number: 3235-0362
Expires: January 31, 2005
Estimated average burden
hours per response. . . . . 1.0
1. Name and Address of Reporting Person*
Traverso, Kenneth M.

(Last)                      (First)                      (Middle)
c/o Natus Medical Incorporated
1501 Industrial Road

(Street)
San Carlos,    CA   94070

(City)                      (State)                      (Zip)

2. Issuer Name
and Ticker or Trading Symbol

Natus Medical Incorporated
BABY

3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)
4. Statement for
    Month/Year

12/31/2002


5. If Amendment,
    Date of Original
    (Month/Year)

12/2002
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

   Director      10% Owner
X Officer (give title below)        Other (specify below)

Description           Vice President Worldwide Sales

7. Individual or Joint/Group
    Filing (Check Applicable Line)

X   Form filed by One Reporting Person
     Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security
    (Instr. 3)

2.Transaction
Date
(Month/Day/Year)
2A. Deemed Execution Date, if any
(Month/Day/Year)
3. Transaction
    Code
    (Instr. 8)
4. Securities Acquired (A) or Disposed Of (D)
    (Instr. 3, 4, and 5)





        Amount      /         A/D         /         Price          
5. Amount of
    Securities
    Beneficially
    Owned at end of
    Issuer's Fiscal Year

    (Instr. 3 and 4)
6. Owner-
    ship
    Form:
    Direct (D)
    or
    Indirect (I)

    (Instr. 4)
7. Nature of
     Indirect
     Beneficial
     Ownership

    (Instr. 4)
Common Stock
10/31/2002
10/31/2002
M
3,576 (1) / A / $2.975
124,430
D
/ / $
4,100
I
Lisa M. Traverso IRA
/ / $
10,500
I
Kenneth Traverso IRA
/ / $
8,572
I
By Trust

 
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
    (Instr. 3)
2. Conver-
    sion or
    Exercise
    Price of
    Deri-
    vative
    Security
3. Transaction Date

(Month/
Day/
Year)
3A. Deemed Execution Date, if any

(Month/
Day/
Year)
4. Transaction Code
    (Instr.8)
5. Number of Derivative
    Securities Acquired (A)
    or Disposed Of (D)

    (Instr. 3, 4 and 5)





  A     or     D  
6. Date Exercisable(DE) and
    Expiration Date(ED)
    (Month/Day/Year)






  DE     /     ED  
7. Title and Amount of
    Underlying Securities
    (Instr. 3 and 4)






Title     /         Amount or Number of Shares
8. Price
    of
    Derivative
    Security
    (Instr.5)
9. Number of
    Derivative
    Securities
    Beneficially
    Owned
    at End of Year
    Reported
    Transaction(s)
    (Instr.4)
10. Owner-
ship
Form of
Deriv-
ative
Securities:
Direct (D)
or
Indirect (I)

(Instr.4)
11. Nature of
      Indirect
      Beneficial
      Ownership
      (Instr.4)
Incentive Stock Option (Right to Buy) $4.149 06/14/2002 06/14/2002
A
15,256 A
07/14/2002 / 06/14/2012
Common Stock / 15,256
$4.149
15,256
D
Nonstatutory Stock Option (Right to Buy) $4.149 06/14/2002 06/14/2002
A
9,744 A
07/14/2002 / 06/14/2012
Common Stock / 9,744
$4.149
9,744
D
Explanation of Responses:
 
(1) Shares issued pursuant to Issuer's Employee Stock Purchase Plan

(2) Represents an option in which 1/48th of the shares underlying the option become vested amd exercisable each month after the vesting commencement date defined in the Option Agreement.

By: Date:
/s/ Kenneth M. Traverso 03/13/2003
Kenneth M. Traverso, Vice President Worldwide Sales
** Signature of Reporting Person
SEC 2270 (09-02)


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB Number.